Trifocal IOLs useful for intermediate vision

Article

Two trifocal IOLs enabled patients to have "a useful third focus for intermediate vision", but also resulted in increased background halos and reduced distance visual quality compared with a multifocal IOL, according to new research.

Two trifocal IOLs (AT LISA tri, Carl Zeiss Meditec; FineVision, PhysIOL) enabled patients in whom they were used to have "a useful third focus for intermediate vision," but they also resulted in increased background halos and reduced distance visual quality for users compared with the vision experienced by recipients of two powers (+2.5 D and +3.0 D) of a multifocal IOL (ReSTOR, Alcon), according to new research published in Clinical Ophthalmology. Three of the four authors work for Alcon Research.

The researchers used a Badal optometer and a Snellen visual acuity chart to evaluate all of the implants for resolution, image quality and photic phenomena. They found that resolution equivalent to 20/40 Snellen visual acuity was achieved over almost all of the viewing distance range in those receiving the trifocal implants, but background shadows were more noticeable for those with the trifocal lenses than they were for study participants receiving the multifocal lens.

The authors obtained simulated headlight images using a modulation transfer function (MTF) bench and a 50-μm pinhole target. They determined far, intermediate, and near distance MTF values using vertical and horizontal slits.

The researchers found that distance MTF peaks at 20/20 Snellen–equivalent spatial frequency were greatest for the multifocal IOLs. The near MTF peak with the +2.5 D multifocal IOL occurred at 53 cm and had a 20/20 Snellen–equivalent value; this was lower than the near peaks of the other study lenses but higher than the intermediate foci of both of the trifocal IOLs.

"Based on this laboratory simulation," the authors write, "the ReSTOR +3.0 D is expected to provide high-quality distance and near vision, with a low propensity for halos. The ReSTOR +2.5 D is expected to provide the best distance vision, with low halo intensity and intermediate vision around 50 to 60 cm. The two trifocal IOLs provide improved intermediate vision in the 70 to 80 cm range, although this benefit may come at the expense of increased nighttime halos."

To read the full article, click here.

Newsletter

Join ophthalmologists across Europe—sign up for exclusive updates and innovations in surgical techniques and clinical care.

Recent Videos
Christine Curcio, PhD, of the University of Alabama at Birmingham Heersink School of Medicine, shares histology update and revised nomenclature for OCT with Sheryl Stevenson of the Eye Care Network and Ophthalmology Times
SriniVas R. Sadda, MD, FARVO, shares key points from his retina presentation at the International SPECTRALIS Symposium
Robert Sergott, MD, describes fluorescence lifetime imaging ophthalmoscopy (FLIO) and the International SPECTRALIS Symposium – And Beyond (ISS) in Heidelberg, Germany.
Rayaz Malik, MBChB, PhD, a professor of medicine at Weill Cornell Medicine - Qatar, spoke with Ophthalmology Times Europe about his presentation. It's titled "An eye on neurodegenerative diseases: Challenging the dogma" at the International SPECTRALIS Sympsoium. In conversation with Hattie Hayes, Ophthalmology Times Europe
Anat Loewenstein, MD, describes her presentation on remote imaging for age-related macular degeneration and geographic atrophy at the International SPECTRALIS Symposium, in conversation with Hattie Hayes of Ophthalmology Times Europe
Tyson Brunstetter, OD, PhD, a US Navy Aerospace Optometrist at the NASA Johnson Space Center in Houston, Texas, shares key takeaways from his keynote at the International SPECTRALIS Symposium (ISS)
Rayaz Malik, MBChB, PhD, shares his presentation, titled An eye on neurodegenerative diseases: Challenging the dogma, at this year's International SPECTRALIS Symposium
At the Retina World Congress, Siegfried Priglinger, MD, speaks about ensuring the best outcomes for preschool-aged patients
At the 2025 ASCRS meeting, Robert Ang, MD said small aperture IOLs can benefit all patients, especially those with complex corneas or who have undergone previous corneal refractive surgery
Viha Vig, MBChB graduate student at the University of Auckland, New Zealand, discusses her poster presentation on the relationship between mitochondiral disease, Alzheimer disease, and other types of dementia.
© 2025 MJH Life Sciences

All rights reserved.